NAPLEX common mistakes
NAPLEX · Understand the traps and how to avoid them.
Choosing the first-line drug for a disease by recalling a brand name from a top-200 drug list rather than applying the guideline-recommended drug class and patient-specific contraindications.
Candidates often study drug cards in isolation, so they recognize names but have not built disease-based treatment algorithms.
What to do instead
For each high-yield condition (HFrEF, type 2 diabetes, asthma, community-acquired pneumonia, VTE), write a one-page algorithm listing first-line therapy, add-on therapy, contraindications, and monitoring, then answer 10 vignettes using only that algorithm.
Calculating a weight-based dose but dropping unit labels (lb vs kg, mcg vs mg) and selecting an answer that is off by a factor of 1,000.
Mental math and shortcut formulas encourage candidates to skip dimensional analysis and forget to convert pounds to kilograms or micrograms to milligrams.
What to do instead
Write every conversion as a dimensional-analysis equation with units canceling, estimate the expected order of magnitude before computing, and compare the result to the maximum dose and available dosage forms.
Recommending a standard adult dose without calculating creatinine clearance for a patient whose age, weight, and serum creatinine are provided.
Renal adjustment is treated as an optional afterthought rather than a mandatory step in every patient case.
What to do instead
At the start of every case, calculate Cockcroft-Gault CrCl and list which of the candidate drugs are renally eliminated; use a renal dosing table for high-yield drugs (antimicrobials, anticoagulants, gabapentin, metformin).
Treating all controlled substances as Schedule II, such as allowing refills on a CII prescription or assuming a CII can be transferred between pharmacies.
Schedule distinctions are memorized as isolated facts rather than applied to prescription-processing scenarios.
What to do instead
Build a controlled-substance table with columns for refills, transfers, partial fills, and emergency oral orders, then apply it to at least 10 scenario questions until the CII rules are automatic.
Counseling a patient by reading the auxiliary label ('may cause drowsiness') without stating how to take the medication, what to do about a missed dose, or when to call the prescriber.
Candidates mimic the label instead of using a structured counseling framework, so the response is incomplete.
What to do instead
Use the three prime questions (What did your prescriber tell you this is for? How were you told to take it? What did you expect?) plus a checklist: indication, administration, duration, missed dose, adverse effects, monitoring, storage.
Assigning the same beyond-use date to every sterile compounded preparation regardless of risk level, storage temperature, or whether it was prepared in an ISO Class 5 environment.
BUD rules are memorized as a single number instead of as a risk-level and storage-condition matrix.
What to do instead
Create a BUD table organized by CSP risk level (immediate use, low, medium, high) and storage temperature, and practice distinguishing manufacturer expiration dating from beyond-use dating.
During a drug recall scenario, removing recalled stock from the shelf but failing to document the lot number, quantity, or patients who received the product.
Recall response is learned as a shelf-clearing action rather than a documented, patient-centered process.
What to do instead
Use a recall checklist: quarantine and label stock, record lot and quantity, identify and notify affected patients, document return or destruction, and verify no remaining stock.
Screening only for CYP450 metabolic interactions and missing pharmacodynamic duplication such as combined serotonergic agents, additive QT prolongation, or overlapping anticoagulant/antiplatelet therapy.
Interaction study focuses on metabolic pathways, so pharmacodynamic and disease-state interactions are not systematically considered.
What to do instead
Screen every regimen in three buckets: metabolic (CYP450, transporters), pharmacodynamic (additive toxicity or effect), and disease-state contraindications; practice by listing all three for each new drug.
Calculating an IV infusion rate in mL/hr but reporting the answer in drops/min, or using the wrong time period (per minute vs per hour) in the final step.
Rate units are confused during the last conversion, and candidates do not anchor the answer to the requested unit.
What to do instead
Write the requested answer unit first, set up dimensional analysis to arrive at that unit, and sanity-check against a typical pump rate and the prescribed dose per hour.
Calculating a loading dose from clearance or half-life, or predicting time to steady state without accounting for altered volume of distribution or renal impairment.
Pharmacokinetic formulas are memorized as interchangeable equations rather than as distinct concepts.
What to do instead
Separate the concepts explicitly: loading dose = Vd × target concentration; maintenance dose = clearance × target concentration; half-life governs accumulation to steady state; then re-derive each in practice cases with organ dysfunction.